Sibylla Biotech Competitors and Similar CompaniesClear all
AEON Biopharma's competitors and similar companies include Cingulate and e-therapeutics.
 AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. |  Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. | ||
Founding Date | Founding Date 2012 | Founding Date 2021 | Founding Date 2003 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Irvine, US HQ Newport Beach, US | Locations Kansas City, US HQ Morristown, US | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 6 | Employees 13 | Employees 58 |
Valuation ($) | Valuation ($) 39.5 m | Valuation ($) 13.2 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($39.2m) (FY, 2025) | Net income ($22.4m) (FY, 2025) | Net income (£14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 112.6m | Total funding raised N/A | Total funding raised $ 66.8m |
For sources of this data, please see the company profile
View Company Profiles
Cingulate
HQ
Kansas City, US
Employees
13
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View company
e-therapeutics
HQ
Long Hanborough, GB
Employees
58
e-therapeutics is a computational drug discovery company.
View company